Clinical Trial Results:
A Phase I/II Trial of BMS-754807 in Combination with Trastuzumab (Herceptin®) in Subjects with Advanced or Metastatic Her-2-positive Breast Cancer
Revised Protocol Number 01 (version 2.0, dated 01-Jun-09), incorporating Administrative Letter 01 and Amendment 03.
+ Pharmacogenetics Blood Sample Amendment Number 01 - Site Specific (version 1.0 dated 13-Aug-08)
+ Administrative Letter 02, dated 01-Sep-09
Summary
|
|
EudraCT number |
2009-013766-78 |
Trial protocol |
HU GB BE NL |
Global completion date |
15 Jan 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Dec 2016
|
First version publication date |
07 Dec 2016
|
Other versions |
|
Summary report(s) |
CA191-004_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.